RESULTS

RNA Modification in Inflammatory Bowel Diseases (Biomedicines, 2022)

Inflammatory bowel disease (IBD) is a chronic inflammatory disorder characterized by damage to the intestinal mucosa. Some populations with IBD show a cancer-prone phenotype. Recent studies have provided insight into the involvement of RNA modifications in the specific pathogenesis of IBD through regulation of RNA biology in epithelial and immune cells. We note a new awareness of RNA modification in the targeting of IBD and related diseases.